Bayer Statements
BA
Bayer Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
33 568
100
20 064
62.4
13 504
37.6
—
0
1 941
6.2
6 638
19.5
6 866
18.1
-116
-0.2
368
1
7 118
18.9
1 604
5.1
5 514
13.8
122.69
44.942
31 193
100
17 397
60.6
13 796
39.4
—
0
2 548
8.9
7 847
24
5 949
15.3
-116
-0.5
280
1
6 113
15.8
1 461
4.6
4 652
11.2
103.37
45
19 534
100
10 421
49.5
9 113
50.5
—
0
2 560
12
6 799
31.8
2 314
18.6
-81
-0.6
255
1.6
3 073
19.7
698
3.8
2 375
15.9
52.77
45
27 810
100
16 221
61.2
11 589
38.8
—
0
2 071
7.3
6 437
23.6
5 152
15.2
-48
-0.2
291
1
5 395
16.1
1 317
4.8
4 078
11.3
90.61
45
16 519
100
9 519
55.4
7 000
44.6
—
0
1 915
13.2
5 472
36.3
1 528
8.3
-74
-0.5
342
2.2
1 859
10.9
1 691
2.4
168
8.4
3.74
45
26 094
100
14 940
61.3
11 154
38.7
—
0
1 707
5.6
5 300
18.1
5 854
20.5
-52
-0.2
296
1.1
6 086
21.4
1 323
5.2
4 763
16.3
105.84
45
13 127
100
6 521
41.7
6 606
58.3
—
0
1 739
20.4
4 761
49.8
1 845
8.5
-62
-0.6
372
3.9
1 898
5.6
204
-1.3
1 694
6.9
37.63
45
22 967
100
12 577
57.9
10 390
42.1
—
0
1 877
6.8
5 624
20.6
4 766
21.5
-76
-0.3
288
0.8
3 933
16
882
3.4
3 051
12.6
89.73
34
10 273
100
5 082
35.2
5 191
64.8
—
0
2 007
42.1
5 518
106.1
-327
-41.3
-43
-0.2
257
3.8
-113
-37.7
-173
-15.03
60
-22.6
2.24
34.5
21 400
100
11 532
58.2
9 868
41.8
—
0
1 635
7
5 168
23.2
4 700
18.6
-61
-0.3
274
1.2
4 913
19.5
1 602
6
3 311
13.5
97.37
34